The prostate drug CyPat and the oral contraceptive Seasonale are in final-stage trials.
Approvals in the U.S. and Europe had allowed for the launch of new drugs like the prostate drug Zytiga and the pain drug Nucynta.
FORBES: JNJ Profit Drops, Revenue Jumps As New Drugs Are Rolled Out
Another big winner was Exelixis, which saw good results from its prostate cancer drug.
Abiraterone is dramatically different in several ways from another high-profile prostate cancer drug, Provenge, from Dendreon of Seattle.
AstraZeneca is also seeking permission to promote more broadly Casodex, its prostate cancer drug, and Arimidex, its breast cancer drug.
In May 2007 the FDA rejected Dendreon's prostate cancer drug Provenge even though an advisory panel had voted to approve it.
The much-watched prostate cancer drug Provenge, made by Seattle's Dendreon, showed some promise in a planned peek at the results of an uncompleted study.
Dendreon (nasdaq: DNDN - news - people )'s prostate cancer drug Provenge even though an advisory panel had voted to approve it.
Two years ago, a panel rejected Xinlay, a prostate cancer drug from Abbott Laboratories, because the only evidence for its effectiveness came from after-the-fact analyses of two clinical trials.
Awaiting the FDA's nod this year are Crestor, a potent cholesterol buster, as well as permission to more broadly promote Casodex, its prostate cancer drug, and Arimidex, its breast cancer drug.
Approvals for new drugs such as Stelara, which treats psoriasis, the prostate cancer drug Zytiga and the adult schizophrenia drug Invega Sustenna, showed strong sales results during the quarter, the company said.
FORBES: Johnson & Johnson Beats Estimates, Profit Falls On Domestic Recalls
Two years ago, a panel rejected Xinlay, a prostate cancer drug from Abbott Laboratories (nyse: ABT - news - people ), because the only evidence for its effectiveness came from after-the-fact analyses of two clinical trials.
Scouring patent databases, Dr. Jung discovered a compound made by the former French drug maker Roussel Uclaf that locked onto the androgen receptor about 100 times more strongly than the commonly used prostate-cancer drug, Casodex.
One of the few precedents for the lorcaserin activism came in the fight over the prostate-cancer drug Provenge, which was rejected by the FDA in 2007.
When the mice were kept calm and free of stress, the drug destroyed prostate cancer cells and inhibited tumor growth.
Throughout the 1990s, many urologists had supplemented their revenues through an arrangement with the maker of Lupron, a hormone drug for prostate cancer.
One model used mice that were implanted with human prostate cancer cells and treated with a drug that is currently in clinical trial for prostate cancer treatment.
When the mice were treated with bicalutamide, a drug currently used to treat prostate cancer, their prostate tumors decreased in size.
Statistical rules aside, Provenge fans say, survival is awfully hard to fake, and desperate metastatic prostate cancer patients who would get Provenge have only one drug, the chemotherapy Taxotere, at their disposal.
The studies include trials aiming to show that can prevent fractures in women with osteoporosis or at risk for it, as well as studies to prove the drug help prevent bone problems in patients with prostate and breast cancer.
According to a study published in tomorrow's New England Journal of Medicine (NEJM), a drug called pamidronate can prevent such bone weakening in prostate cancer patients.
"We will research a new drug combination therapy which aims to specifically target aggressive prostate tumours to control their growth and, most importantly, reduce the number of tumours which form in other areas of the body, " she said.
BBC: Prostate cancer research grant for University of Ulster
It is testing the new drug against lung cancer, stomach-lining tumors and prostate cancer as well.
Its lead drug candidate will remain Provenge, a vaccine to treat prostate cancer.
Millennium's drug, now in early human trials, homes in on prostate cancer cells and aims to obliterate them with a precise dose of toxic chemotherapy while leaving surrounding tissue untouched.
In addition, 54% of MDV3100 patients compared to 1.5% of those on placebo had a greater than 50% reduction in a marker called prostate specific antigen an indicator of a positive response to the drug.
Since more than 200, 000 men in the United States are diagnosed with prostate cancer each year, this could be a windfall for the Swiss drug giant, already flying high after its leukemia treatment Gleevec was approved in record time by U.S. regulators this May.
Late last year, the drug chalked up a medical first when it became the first drug to delay the onset of bone metastases in high-risk prostate cancer patients who were failing hormone therapy.
FORBES: Amgen Exec: "Clearly Superior" Prostate Cancer Drug Will Be Huge
The promise of new chemo drugs got a boost in the spring when studies found that the cancer drug Taxotere, made by Sanofi-Aventis, extended survival in prostate cases from 16 months to 18 months, the first time any chemo agent had been found to extend the life of prostate patients.
That makes it a promising drug target for Myriad, already well known for discovering genes linked to prostate, ovarian and breast cancers.
应用推荐